Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients
- PMID: 36317385
- DOI: 10.1111/1346-8138.16621
Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients
Abstract
Nagashima-type palmoplantar keratoderma (NPPK) is the most prevalent hereditary palmoplantar keratoderma (PPK) in China, but there is a paucity of epidemiological data on the Chinese population. To explore the clinical and genetic characteristics, evaluate the demographic distribution, and estimate the burden of disease of NPPK. A total of 234 Chinese patients with NPPK were enrolled from two medical centers and an online PPK support group. Next-generation sequencing and Sanger sequencing were performed to screen out and confirm pathogenic mutations in SERPINB7. Clinical features and quality of life (QOL) were evaluated using self-completed questionnaires. In total, 14 pathogenic mutations were identified in SERPINB7 from the cohort. The top four recurrent mutations were c.796C>T (355, 75.9%), c.522dupT (66, 14.1%), c.650_653delCTGT (24, 5.1%), and c.455G>T (12, 2.6%), accounting for 97.6% of Chinese NPPK patients. Other mutations (11, 2.4%) include c.455-1G>T, c.336+2T>G, c.635delG and seven novel mutations c.2T>C, c.434delG, c.455-16A>G, c.656T>C, c.745-553T>G, c.832C>T, c.1036G>T. The estimated prevalence of NPPK in China was found to be 0.975/10 000 based on Chinese databases. Clinically, there were no apparent genotype-phenotype correlations in NPPK patients. Pediatric patients mainly presented with palmoplantar peeling, while adults presented with scale (p < 0.001). The most common comorbidities in NPPK patients were onychomycosis (40.0%), eczema (36.8%), and tinea pedis (30.3%). As for burden of disease, NPPK patients' QOL was decreased by a moderate degree. In this study, pathogenic mutations' allele frequencies in SERPINB7 were updated, and prevalence of NPPK in China was estimated. This large-scale cohort study provides evidence-based recommendations for patient management. Identification of new mutations are important for timely diagnosis of NPPK. Palmoplantar peeling in children can be used as a hallmark for early recognition of NPPK.
Keywords: SERPINB7; Nagashima-type palmoplantar keratoderma; epidemiological; genotype; phenotype.
© 2022 Japanese Dermatological Association.
References
REFERENCES
-
- Kabashima K, Sakabe J, Yamada Y, Tokura Y. “Nagashima-type” keratosis as a novel entity in the palmoplantar keratoderma category. Arch Dermatol. 2008;144:375-9.
-
- Yin J, Xu G, Wang H, Zhao J, Duo L, Cao X, et al. New and recurrent SERPINB7 mutations in seven Chinese patients with Nagashima-type palmoplantar keratosis. J Invest Dermatol. 2014;134:2269-72.
-
- Yamauchi A, Kubo A, Ono N, Shiohama A, Tsuruta D, Fukai K. Three cases of Nagashima-type palmoplantar keratosis associated with atopic dermatitis: a diagnostic pitfall. J Dermatol. 2018;45:e112-e3.
-
- Kubo A, Shiohama A, Sasaki T, Nakabayashi K, Kawasaki H, Atsugi T, et al. Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis. Am J Hum Genet. 2013;93:945-56.
-
- Ito Y, Takeichi T, Ikeda K, Tanahashi K, Yoshikawa T, Murase Y, et al. Updated allele frequencies of SERPINB7 founder mutations in Asian patients with Nagashima-type palmoplantar keratosis/keratoderma. J Dermatol Sci. 2021;103:116-9.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
